CA2931606A1 - Improved process for the preparation of pomalidomide and its purification - Google Patents

Improved process for the preparation of pomalidomide and its purification Download PDF

Info

Publication number
CA2931606A1
CA2931606A1 CA2931606A CA2931606A CA2931606A1 CA 2931606 A1 CA2931606 A1 CA 2931606A1 CA 2931606 A CA2931606 A CA 2931606A CA 2931606 A CA2931606 A CA 2931606A CA 2931606 A1 CA2931606 A1 CA 2931606A1
Authority
CA
Canada
Prior art keywords
pomalidomide
solvent
group
process according
dione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2931606A
Other languages
English (en)
French (fr)
Inventor
Vinayak Gore
Vinay Kumar Shukla
Dhananjay Shinde
Bansode PRAKASH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Laboratories Ltd
Original Assignee
Mylan Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Laboratories Ltd filed Critical Mylan Laboratories Ltd
Priority claimed from IN5409CH2013 external-priority patent/IN2013CH05409A/en
Publication of CA2931606A1 publication Critical patent/CA2931606A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CA2931606A 2013-11-25 2014-11-24 Improved process for the preparation of pomalidomide and its purification Abandoned CA2931606A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN5409/CHE/2013 2013-11-25
IN424/CHE/2014 2014-01-30
IN424CH2014 2014-01-30
IN5409CH2013 IN2013CH05409A (enExample) 2013-11-25 2014-11-24
PCT/IB2014/066285 WO2015075694A1 (en) 2013-11-25 2014-11-24 Improved process for the preparation of pomalidomide and its purification

Publications (1)

Publication Number Publication Date
CA2931606A1 true CA2931606A1 (en) 2015-05-28

Family

ID=52350154

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2931606A Abandoned CA2931606A1 (en) 2013-11-25 2014-11-24 Improved process for the preparation of pomalidomide and its purification

Country Status (9)

Country Link
US (1) US20160362391A1 (enExample)
EP (1) EP3074383B1 (enExample)
JP (1) JP6644685B2 (enExample)
AU (1) AU2014351354B2 (enExample)
BR (1) BR112016011700B1 (enExample)
CA (1) CA2931606A1 (enExample)
ES (1) ES2694512T3 (enExample)
TR (1) TR201816539T4 (enExample)
WO (1) WO2015075694A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104557858B (zh) * 2013-10-29 2018-06-01 上海医药工业研究院 一种泊利度胺的制备方法
HU231259B1 (hu) 2016-02-04 2022-06-28 Egyt Gyogyszervegyeszeti Gyar Eljárás pomalidomide elõállítására
CN105924426B (zh) * 2016-06-20 2019-03-08 浙江海正药业股份有限公司 一种泊马度胺的结晶工艺
CN105866297B (zh) * 2016-06-24 2019-01-04 合肥久诺医药科技有限公司 一种泊马度胺有关物质的高效液相色谱分析方法
CN106565668B (zh) * 2016-10-27 2020-01-10 扬子江药业集团有限公司 一种高纯度泊马度胺的制备方法
WO2018154516A1 (en) * 2017-02-23 2018-08-30 Sun Pharmaceutical Industries Limited Process for the preparation of pomalidomide
CN114605381A (zh) * 2020-12-03 2022-06-10 南京海辰药业股份有限公司 一种泊马度胺的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281230B1 (en) * 1996-07-24 2001-08-28 Celgene Corporation Isoindolines, method of use, and pharmaceutical compositions
US5635517B1 (en) * 1996-07-24 1999-06-29 Celgene Corp Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines
US6660736B2 (en) * 2002-03-27 2003-12-09 Hoffmann-La Roche Inc. Phthalimido derivatives and a process for their preparation
DK2380887T3 (da) * 2005-06-30 2013-10-07 Celgene Corp Fremgangsmåder til fremstilling af 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindolin-1,3-dion-forbindelser
US20120302605A1 (en) * 2010-11-18 2012-11-29 Deuteria Pharmaceuticals, Llc 3-deutero-pomalidomide
US20140221427A1 (en) * 2011-06-22 2014-08-07 Celgene Corporation Isotopologues of pomalidomide
WO2013126326A1 (en) * 2012-02-21 2013-08-29 Celgene Corporation Solid forms of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, compositions and methods of use thereof
WO2014170909A2 (en) * 2013-04-01 2014-10-23 Hetero Research Foundation Process for pomalidomide
CN103275062B (zh) * 2013-05-17 2016-04-13 宁波百思佳医药科技有限公司 一种Pomalidomide的纯化方法
CN103288797B (zh) * 2013-05-17 2016-03-02 宁波百思佳医药科技有限公司 一种用亚砜类溶剂纯化Pomalidomide的方法

Also Published As

Publication number Publication date
US20160362391A1 (en) 2016-12-15
JP2017505286A (ja) 2017-02-16
WO2015075694A1 (en) 2015-05-28
JP6644685B2 (ja) 2020-02-12
EP3074383B1 (en) 2018-10-10
BR112016011700B1 (pt) 2022-08-23
ES2694512T3 (es) 2018-12-21
BR112016011700A2 (pt) 2017-10-10
AU2014351354B2 (en) 2018-11-08
AU2014351354A1 (en) 2016-06-16
EP3074383A1 (en) 2016-10-05
TR201816539T4 (tr) 2018-11-21

Similar Documents

Publication Publication Date Title
EP3074383B1 (en) Improved process for the preparation of pomalidomide and its purification
AU2004213616B2 (en) A process of preparing imatinib
CA2717326C (en) Preparation of lenalidomide
AU2002344419B2 (en) Alpha-form or beta-form cyrstal of acetanilide derivative
JP6659554B2 (ja) 高純度キノリン誘導体およびその製造方法
AU2010220204B2 (en) Improved process
AU2015360270B2 (en) Piperidine derivatives as HDAC1/2 inhibitors
RU2467012C2 (ru) Способ очистки стауроспорина и способ получения n-бензоилстауроспорина
CA2772080C (en) Synthesis of a neurostimulative piperazine
KR20090128396A (ko) 이마티니브 메실레이트
WO2011033307A1 (en) Nilotinib dihydrochloride salt
WO2019026014A1 (en) METHODS FOR PREPARING LIFITEGRAST AND ITS INTERMEDIATES
EP2350055A1 (en) Lenalidomide solvates and processes
CN102675395B (zh) 醋酸乌利司他的多晶型及其制备方法
ES2452940T3 (es) Procedimiento novedoso de preparación de base de imatinib
KR102484846B1 (ko) 벤조피란 유도체의 정제방법, 이의 결정형 및 상기 결정형의 제조방법
CA2515130A1 (en) Method of stabilizing lansoprazole
US20240239791A1 (en) Processes for the synthesis of valbenazine
JP2012500276A (ja) グラニセトロン塩酸塩の多形体とその製造方法
CN112119058A (zh) 制备哌马色林碱的方法
WO2016038590A1 (en) Process for the preparation of crystalline form i of regorafenib

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20191125

FZDE Discontinued

Effective date: 20220711

FZDE Discontinued

Effective date: 20220711

FZDE Discontinued

Effective date: 20220711